William Cruz‐Muñoz

Biochemistry, Genetics and Molecular Biology · Life Sciences

19h-index3.1kcitations72works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Melanoma and MAPK Pathways(33), Brain Metastases and Treatment(27), Nanoplatforms for cancer theranostics(11), Cancer Cells and Metastasis(9), RNA Interference and Gene Delivery(6)

Publications72 total

Modulation of fibronectin extracellular matrix enhances anti-tumor efficacy of immune checkpoint blockade
Cell Reports Medicine·2025Open Access
Supplementary Figure S4 from PLEKHA5 as a Biomarker and Potential Mediator of Melanoma Brain Metastasis
2023Open Access
Supplementary Table S1 from PLEKHA5 as a Biomarker and Potential Mediator of Melanoma Brain Metastasis
2023Open Access
Data from PLEKHA5 as a Biomarker and Potential Mediator of Melanoma Brain Metastasis
2023Open Access
Supplementary Figure Legends from PLEKHA5 as a Biomarker and Potential Mediator of Melanoma Brain Metastasis
2023Open Access
Supplementary Table S3 from PLEKHA5 as a Biomarker and Potential Mediator of Melanoma Brain Metastasis
2023Open Access
Supplementary Figure S2 from PLEKHA5 as a Biomarker and Potential Mediator of Melanoma Brain Metastasis
2023Open Access
Supplementary Table S2 from PLEKHA5 as a Biomarker and Potential Mediator of Melanoma Brain Metastasis
2023Open Access
Supplementary Materials and Methods from PLEKHA5 as a Biomarker and Potential Mediator of Melanoma Brain Metastasis
2023Open Access
Supplementary Figure S2 from PLEKHA5 as a Biomarker and Potential Mediator of Melanoma Brain Metastasis
2023Open Access
Supplementary Figure S1 from PLEKHA5 as a Biomarker and Potential Mediator of Melanoma Brain Metastasis
2023Open Access
Supplementary Table S1 from PLEKHA5 as a Biomarker and Potential Mediator of Melanoma Brain Metastasis
2023Open Access
Supplementary Materials and Methods from PLEKHA5 as a Biomarker and Potential Mediator of Melanoma Brain Metastasis
2023Open Access
Supplementary Figure S3 from PLEKHA5 as a Biomarker and Potential Mediator of Melanoma Brain Metastasis
2023Open Access
Data from PLEKHA5 as a Biomarker and Potential Mediator of Melanoma Brain Metastasis
2023Open Access
Supplementary Figure S1 from PLEKHA5 as a Biomarker and Potential Mediator of Melanoma Brain Metastasis
2023Open Access
Supplementary Figure Legends from PLEKHA5 as a Biomarker and Potential Mediator of Melanoma Brain Metastasis
2023Open Access
Supplementary Figure S4 from PLEKHA5 as a Biomarker and Potential Mediator of Melanoma Brain Metastasis
2023Open Access
Supplementary Table S2 from PLEKHA5 as a Biomarker and Potential Mediator of Melanoma Brain Metastasis
2023Open Access
Supplementary Figure S3 from PLEKHA5 as a Biomarker and Potential Mediator of Melanoma Brain Metastasis
2023Open Access
page 1 of 4Next →

Frequent Co-authors

Robert S. Kerbel(43), Shan Man(25), Giulio Francia(19), María Jaramillo(14), M. Banville(14), Maureen D. O'Connor‐McCourt(14), André Nantel(13), Sherif S. Morgan(13), Lee D. Cranmer(13), Ping Xu(12), Catherine Collins(12), Lucia B. Jilaveanu(10), Fabio Parisi(10), Meaghan L. Barr(10), Christopher R. Zito(10), David L. Rimm(10), Marcus Bosenberg(10), Ruth Halaban(10), Yuval Kluger(10), Harriet M. Kluger(10)